Suivre
Donna D. Zhang
Donna D. Zhang
Adresse e-mail validée de pharmacy.arizona.edu
Titre
Citée par
Citée par
Année
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13833*2021
Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease
BR Stockwell, JPF Angeli, H Bayir, AI Bush, M Conrad, SJ Dixon, S Fulda, ...
Cell 171 (2), 273-285, 2017
54192017
Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress
DD Zhang, M Hannink
Molecular and cellular biology, 2003
16752003
Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival
SB Cullinan, D Zhang, M Hannink, E Arvisais, RJ Kaufman, JA Diehl
Molecular and cellular biology 23 (20), 7198-7209, 2003
14522003
Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex
DD Zhang, SC Lo, JV Cross, DJ Templeton, M Hannink
Molecular and cellular biology, 2004
14472004
NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
M Dodson, R Castro-Portuguez, DD Zhang
Redox biology 23, 101107, 2019
14082019
The emerging role of the Nrf2–Keap1 signaling pathway in cancer
MC Jaramillo, DD Zhang
Genes & development 27 (20), 2179-2191, 2013
14052013
Mechanistic studies of the Nrf2-Keap1 signaling pathway
DD Zhang
Drug metabolism reviews 38 (4), 769-789, 2006
12932006
NRF2 and the Hallmarks of Cancer
MR de la Vega, E Chapman, DD Zhang
Cancer cell 34 (1), 21-43, 2018
11692018
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
XJ Wang, Z Sun, NF Villeneuve, S Zhang, F Zhao, Y Li, W Chen, X Yi, ...
Carcinogenesis 29 (6), 1235-1243, 2008
9662008
A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62
A Lau, XJ Wang, F Zhao, NF Villeneuve, T Wu, T Jiang, Z Sun, E White, ...
Molecular and cellular biology 30 (13), 3275-3285, 2010
8982010
Dual roles of Nrf2 in cancer
A Lau, NF Villeneuve, Z Sun, PK Wong, DD Zhang
Pharmacological research 58 (5-6), 262-270, 2008
8092008
Direct interaction between Nrf2 and p21Cip1/WAF1 upregulates the Nrf2-mediated antioxidant response
W Chen, Z Sun, XJ Wang, T Jiang, Z Huang, D Fang, DD Zhang
Molecular cell 34 (6), 663-673, 2009
7292009
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
D Ren, NF Villeneuve, T Jiang, T Wu, A Lau, HA Toppin, DD Zhang
Proceedings of the National Academy of Sciences 108 (4), 1433-1438, 2011
6892011
p62 links autophagy and Nrf2 signaling
T Jiang, B Harder, MR De La Vega, PK Wong, E Chapman, DD Zhang
Free Radical Biology and Medicine 88, 199-204, 2015
5932015
Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy
H Zheng, SA Whitman, W Wu, GT Wondrak, PK Wong, D Fang, DD Zhang
Diabetes 60 (11), 3055-3066, 2011
5742011
The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy
T Jiang, Z Huang, Y Lin, Z Zhang, D Fang, DD Zhang
Diabetes 59 (4), 850-860, 2010
5092010
Regulation of the Nrf2–Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases
NF Villeneuve, A Lau, DD Zhang
Antioxidants & redox signaling 13 (11), 1699-1712, 2010
4582010
Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response
Z Sun, YE Chin, DD Zhang
Molecular and cellular biology, 2009
4432009
Modulating NRF2 in disease: timing is everything
M Dodson, MR de la Vega, AB Cholanians, CJ Schmidlin, E Chapman, ...
Annual review of pharmacology and toxicology 59 (1), 555-575, 2019
4262019
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20